CellLungROS1 oncogenic fusion is reported to be 1% - 2% of non-small cell lung cancers (NSCLCs) of the adenocarcinoma subgroup. Meanwhile, there are no records of squamous cell cancer patients with tumors harboring ROS1 fusions. The Foundation Medicine database indicates a frequency of ROS1 ...
Immunotherapeutic Approaches to the Treatment of Squamous Non-Small Cell Lung CancerR. Herbst
由上海市胸科医院牵头,联合全国74家单位,共同完成了这一大型III期验证性临床研究,发表在76.2分的Lancet Respiratory Medicine。 地址为 发布于 2024-03-13 14:37・IP 属地广东 赞同 1 分享 收藏 写下你的评论... 还没有评论,发表第一个评论吧 ...
Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing. J Clin Oncol. 2018;36(7):633-641. doi:10.1200/JCO.2017.75.3384...
Despite advances in the treatment of patients with nonsquamous non–small-cell lung cancer (NSCLC), lung cancer remains a leading cause of death globally. Studies have demonstrated that survival varies according to histological subtype, and, in many cases, patients with squamous NSCLC have a poorer...
Pemetrexed in Nonsquamous Non–Small-Cell Lung Cancer: The Billion Dollar Subgroup Analysis 来自 NCBI 喜欢 0 阅读量: 10 作者:B Gyawali,V Prasad 摘要: Recently, two clinical trials of novel agents in metastatic ovarian cancer were published: a phase 3 study of nintedanib and a phase 2 study...
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as Treatment for Advanced Squamous Non–Small-Cell Lung Cancer View LargeDownload Figure 1. Study Profile View LargeDownload Patients who discontinued treatment for any reason were included in follow-up. AUC indicates area under the concentration; ...
Lung Diseases Department, San Camillo-Forlanini High Specialization Hospitals, Rome, Italy; 2Sperimental Medicine Department, Rome, Italy Abstract: Pemetrexed is a new cytotoxic agent that is a standard of care for the second-line treatment of non-small cell lung cancer (NSCLC) and in combination...
Italian nivolumab expanded access programme: real-world results in non-squamous non-small cell lung cancer patients Annals of OncologyF. GrossiL. CrinòA. DelmonteD. TurciG. Lo RussoF. De MarinisH.J. Soto ParraD. GalettaF. CappuzzoF. SperandiM. TiseoG. PuppoF. RoilaM.R. MigliorinoG...
Lung Cancer: Targets and Therapy Dovepress open access to scientific and medical research Open Access Full Text Article Review Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer This article was published in the following Dove Press journal: Lung Cancer:Targets ...